Respiratory Syncytial Virus Infections

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Infections, Virus Diseases

Treatments and conditions

Respiratory Syncytial Virus Infections
Treatment and conditionWhere it standsTrials
abrysvo for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
abrysvo + Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beyfortus for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Nirsevimab for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
RSVPreF3 OA investigational vaccine for respiratory syncytial virus infectionsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
S-337395 for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zelicapavir for respiratory syncytial virus infectionsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.